[ad_1]
A wide range of controversies have arisen over the approval of the UK health regulator for the commercialization of Pfizer vaccine. The statement by British Health Minister Matt Hancock that Brexit contributed to this result angered Germany, which responded clearly annoyed with the phrase: “the point is not to be the first».
The issue was raised on the issue of exhaustion of the issue of safety, which through the mouth of the Health Commissioner, Stella Kyriakidou, raised the specific issue. The position that safety prevails over speed in approval was also aligned by the leading US epidemiologist, Anthony Fauci.
The epidemiologist criticized the British regulator, blaming it for the rush.
«They took the data from Pfizer and instead of looking at it carefully, they said “okay, let’s approve the vaccine.”“” Fauci told US network CBS about the British organization.
“The UK ran to the corner of the marathon and took the final steps. They were in a great hurry with this approval.Added.
For many, the traditionally slow pace of European Union decision-making should be abandoned under the circumstances. The EMA announced Tuesday that it will decide until December 29, if you will approve the Pfizer vaccine for January 12 for Modern vaccine. Possibly this wording, “the decision will be taken no later than December 29”, allows the European regulator to “hurry up” in a few days.
Responding to reservations about the “urgency” of London’s decision to approve the vaccine, the British regulatory authority (MHRA) assured that it has evaluated the Pfizer / BioNTech vaccine in accordance with international standards and within the provisions of European legislation. «The way MHRA worked is equivalent to all international standards“He points out in his ad.
As for whether Britain’s withdrawal from the EU affected the speed with which the vaccine was approved, the London government has made it clear that the British regulator has used its provisions. European legislation, which applies until the end of the year ending the Brexit transition period.
«We have been able to authorize the supply of this vaccine using the provisions of European legislation, which is valid until January 1. Our progress was completely dependent on the availability of data in our displacement review and the rigorous evaluation and independent feedback we have received.“says the Directorate General of the British Regulatory Authority.
News Today
What did the rapid tests show in eight prefectures?
Trier video documentary: The jeep passes at breakneck speed and falls on pedestrians
Rapid deterioration of the weather in the next few hours – Which areas will be affected
